Cargando…
RUNX Proteins as Epigenetic Modulators in Cancer
RUNX proteins are highly conserved in metazoans and perform critical functions during development. Dysregulation of RUNX proteins through various molecular mechanisms facilitates the development and progression of various cancers, where different RUNX proteins show tumor type-specific functions and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688118/ https://www.ncbi.nlm.nih.gov/pubmed/36429115 http://dx.doi.org/10.3390/cells11223687 |
_version_ | 1784836186211090432 |
---|---|
author | Yi, Hongyang He, Yuhao Zhu, Qionghua Fang, Liang |
author_facet | Yi, Hongyang He, Yuhao Zhu, Qionghua Fang, Liang |
author_sort | Yi, Hongyang |
collection | PubMed |
description | RUNX proteins are highly conserved in metazoans and perform critical functions during development. Dysregulation of RUNX proteins through various molecular mechanisms facilitates the development and progression of various cancers, where different RUNX proteins show tumor type-specific functions and regulate different aspects of tumorigenesis by cross-talking with different signaling pathways such as Wnt, TGF-β, and Hippo. Molecularly, they could serve as transcription factors (TFs) to activate their direct target genes or interact with many other TFs to modulate chromatin architecture globally. Here, we review the current knowledge on the functions and regulations of RUNX proteins in different cancer types and highlight their potential role as epigenetic modulators in cancer. |
format | Online Article Text |
id | pubmed-9688118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96881182022-11-25 RUNX Proteins as Epigenetic Modulators in Cancer Yi, Hongyang He, Yuhao Zhu, Qionghua Fang, Liang Cells Review RUNX proteins are highly conserved in metazoans and perform critical functions during development. Dysregulation of RUNX proteins through various molecular mechanisms facilitates the development and progression of various cancers, where different RUNX proteins show tumor type-specific functions and regulate different aspects of tumorigenesis by cross-talking with different signaling pathways such as Wnt, TGF-β, and Hippo. Molecularly, they could serve as transcription factors (TFs) to activate their direct target genes or interact with many other TFs to modulate chromatin architecture globally. Here, we review the current knowledge on the functions and regulations of RUNX proteins in different cancer types and highlight their potential role as epigenetic modulators in cancer. MDPI 2022-11-20 /pmc/articles/PMC9688118/ /pubmed/36429115 http://dx.doi.org/10.3390/cells11223687 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Yi, Hongyang He, Yuhao Zhu, Qionghua Fang, Liang RUNX Proteins as Epigenetic Modulators in Cancer |
title | RUNX Proteins as Epigenetic Modulators in Cancer |
title_full | RUNX Proteins as Epigenetic Modulators in Cancer |
title_fullStr | RUNX Proteins as Epigenetic Modulators in Cancer |
title_full_unstemmed | RUNX Proteins as Epigenetic Modulators in Cancer |
title_short | RUNX Proteins as Epigenetic Modulators in Cancer |
title_sort | runx proteins as epigenetic modulators in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688118/ https://www.ncbi.nlm.nih.gov/pubmed/36429115 http://dx.doi.org/10.3390/cells11223687 |
work_keys_str_mv | AT yihongyang runxproteinsasepigeneticmodulatorsincancer AT heyuhao runxproteinsasepigeneticmodulatorsincancer AT zhuqionghua runxproteinsasepigeneticmodulatorsincancer AT fangliang runxproteinsasepigeneticmodulatorsincancer |